Clinical Assessment of Indication for ACE-Inhibitor Treatment Early After Acute Myocardial Infarction

By Schroeder Anne Pauline   Sørensen Keld   Nielsen Jens Cosedis   Rehling Michael   Flø Christian   Sand Niels Peter   Egeblad Henrik  

Scandinavian Cardiovascular Journal, Vol. 33, Iss. 3, 1999-08 ,pp. : 137-142

Informa Healthcare

Access to resources Recommend Favorite

Selective Induction of the Creatine Kinase-B Gene in Chronic Volume Overload Hypertrophy is Not Affected by ACE-inhibitor Therapy

By Schultz D.   Su X.   Bishop S.P.   Billadello J.   dell'Italia L.J.  

Journal of Molecular and Cellular Cardiology, Vol. 29, Iss. 10, 1997-10 ,pp. : 2665-2673

Academic Press

Access to resources Recommend Favorite

A Farnesyltransferase Inhibitor Attenuates Cardiac Myocyte Hypertrophy and Gene Expression

By Calderone A.   Abdelaziz N.   Colombo F.   Schreiber K.L.   Rindt H.  

Journal of Molecular and Cellular Cardiology, Vol. 32, Iss. 6, 2000-06 ,pp. : 1127-1140

Academic Press

Access to resources Recommend Favorite

Angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction in relation to left ventricular function

By Reikvam Aasmund   Kvan Elena   Landmark Knud   Aursnes Ivar  

Scandinavian Cardiovascular Journal, Vol. 37, Iss. 3, 2003-01 ,pp. : 130-134

Informa Healthcare

Access to resources Recommend Favorite

The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction

By Menyar Ayman   Altamimi O.   Gomaa Mohamed   Fawzy Zainab   Rahman M.   Bener Abdulbari  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 235-240

Springer Publishing Company

Access to resources Recommend Favorite